Elevated Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$376K Sell
1,438
-23
-2% -$5.9K 0.11% 91
2026
Q2
$368K Sell
1,461
-25
-2% -$5.38K 0.1% 95
2026
Q1
$323K Buy
1,486
+2
+0.1% +$444 0.11% 104
2025
Q4
$339K Buy
+1,484
New +$338K 0.12% 95

Other funds holding ABBV

Elevated Financial Group's ABBV Position: Q3 2026 in Review

Elevated Financial Group reduced its AbbVie (ABBV) stake by 1.6% in Q3 2026, selling an estimated $5.9K and leaving 1,438 shares worth $376K. The position accounts for 0.11% of the portfolio, ranked #91.

Elevated Financial Group first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 4,278 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Elevated Financial Group held 1,438 shares of AbbVie worth $376K as of Q3 2026.
  • Elevated Financial Group sold 23 AbbVie shares in Q3 2026, an estimated $5.9K.
  • AbbVie made up 0.11% of Elevated Financial Group's portfolio in Q3 2026, its #91 holding.
  • Elevated Financial Group first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 4,278 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Elevated Financial Group's 13F filing for Q3 2026, filed 16 Oct 2026.